IDYA
IDEAYA Biosciences to Participate in Investor Conferences in January 2022
Monday, January 3, 2022 BiopharmaWatch Research 1 min read Key Takeaway: IDEAYA Biosciences to Participate in Investor Conferences in January 2022
Price reaction · baseline $23.64 (2021-12-31 close) · 2 other IDYA headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma
Full Press Release Details
IDEAYA Biosciences to Participate in Investor Conferences in January 2022.